ARAIX
Price
$77.63
Change
-$0.72 (-0.92%)
Updated
Feb 3 closing price
Net Assets
2.73B
JVMTX
Price
$28.85
Change
-$0.78 (-2.63%)
Updated
Feb 3 closing price
Net Assets
24.66B
Interact to see
Advertisement

ARAIX vs JVMTX

Header iconARAIX vs JVMTX Comparison
Open Charts ARAIX vs JVMTXBanner chart's image
Ariel Fund Institutional
Price$77.63
Change-$0.72 (-0.92%)
VolumeN/A
Net Assets2.73B
JHancock Disciplined Value Mid Cap R4
Price$28.85
Change-$0.78 (-2.63%)
VolumeN/A
Net Assets24.66B
ARAIX vs JVMTX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. JVMTX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and JVMTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 24.7B vs. ARAIX (2.73B). JVMTX pays higher dividends than ARAIX: JVMTX (0.60) vs ARAIX (0.11). ARAIX was incepted earlier than JVMTX: ARAIX (14 years) vs JVMTX (13 years). JVMTX (1.10) is less costly to investors than ARAIX (0.69). JVMTX is a more actively managed with annual turnover of: 49.00 vs. ARAIX (17.00). JVMTX has a lower initial minimum investment than ARAIX: JVMTX (0) vs ARAIX (1000000). ARAIX annual gain was more profitable for investors over the last year : 6.50 vs. JVMTX (4.79). JVMTX return over 5 years is better than : 22.28 vs. ARAIX (9.54).
ARAIXJVMTXARAIX / JVMTX
Total Expense Ratio0.690.9970%
Annual Report Gross Expense Ratio0.691.1063%
Fund Existence14 years13 years-
Gain YTD6.2485.177121%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.73B24.7B11%
Annual Yield % from dividends0.110.6019%
Returns for 1 year6.504.79136%
Returns for 3 years9.0811.2281%
Returns for 5 years9.5422.2843%
Returns for 10 years62.3576.8081%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX51.170.44
+0.87%
Eventide Healthcare & Life Sciences N
FGETX25.40N/A
N/A
Fidelity Advisor Glbl Capital Apprec M
JMCCX58.29-0.09
-0.15%
JPMorgan Mid Cap Equity C
AQGIX12.48-0.07
-0.56%
AQR Global Equity I
MSHNX12.87-0.28
-2.13%
Morgan Stanley Inst Permanence A